Skip to content
SPTXSeaport Therapeutics, Inc.

Earnings

When Seaport Therapeutics, Inc. reports, what it reported each quarter, and how the stock took the results.

6 quarters. Mar 31, 2025 to Sep 30, 2026. mixed units.

Quarter by quarter

Q3 2026-$26.39MNo Q3 2025 on file

Latest results

  1. Q3 2026Nov 2, 2026, before the openThe release+2.1%by the close of Nov 2
    Revenue
    —
    —
    Net income
    -$26.39M
    N/M
    EPS
    -$0.49
    N/M
  2. Q2 2026Aug 3, 2026, before the openThe release+0.9%by the close of Aug 3
    Revenue
    —
    —
    Net income
    -$62.60M
    N/M
    EPS
    -$1.78
    N/M
  3. Q1 2026Jun 8, 2026, before the openThe release1.5%by the close of Jun 8
    Revenue
    —
    —
    Net income
    -$25.41M
    N/M
    EPS
    -$10.34
    N/M

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 2, 2026 · pre-marketNov 2, 202633 d10-Q——-$0.49+2.1%
Q2 2026Jun 30, 2026Aug 3, 2026 · pre-marketAug 3, 202634 d10-Q——-$1.78+0.9%
Q1 2026Mar 31, 2026Jun 8, 2026 · pre-marketJun 8, 202669 d10-Q——-$10.341.5%
FY 2025
Q3 2025Sep 30, 2025——————-$9.43—
Q2 2025Jun 30, 2025——————-$6.40—
Q1 2025Mar 31, 2025——————-$5.65—

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 2, 2026442634
10-QAug 3, 2026329537
10-QJun 8, 2026260678

Provenance

ProvenanceData status and checks

Seaport Therapeutics, Inc. · CIK 2042347 · Engraved from SEC EDGAR